Switch to:
More From Other Websites
Pfizer CEO still interested in deals after losing Allergan May 03 2016
Pfizer tops Street 1Q forecasts on higher sales, lower taxes May 03 2016
Pfizer tops Street 1Q forecasts on higher sales, lower taxes May 03 2016
Pfizer Raises Guidance As Lead Drugs Drive Q1 Beat; Stock Up May 03 2016
Perrigo And Allergan Announce First-To-Market Launch Of Store Brand OTC Equivalent To Mucinex®... May 03 2016
Perrigo And Allergan Announce First-To-Market Launch Of Store Brand OTC Equivalent To Mucinex®... May 03 2016
New Scrutiny of M&A Activity Likely to Cost Investment Bankers May 03 2016
Allergan Presents New Data at the American Urological Association Meeting in San Diego May 03 2016
Pfizer earnings rise, boosted by Hospira assets May 03 2016
Allergan Presents New Data at the American Urological Association Meeting in San Diego May 03 2016
The Numbers Don't Lie: Pfizer Earnings Preview May 02 2016
Will the Allergan Fallout Impact Pfizer’s Earnings this Quarter? May 02 2016
Pfizer Stock Rises Ahead of Earnings (PFE, AGN) May 02 2016
Allergan Receives FDA Approval and Launches First Generic Version of CRESTOR® (rosuvastatin) May 02 2016
Allergan Launches Bold Initiative to Help U.S. Military Servicewomen Access LILETTA®... May 02 2016
7:32 am Allergan receives final approval from the the FDA on its aNDA for rosuvastatin calcium 5,... May 02 2016
Allergan Receives FDA Approval and Launches First Generic Version of CRESTOR® (rosuvastatin) May 02 2016
Asanko Gold Refines Scope of Phase 2 Definitive Feasibility Study May 02 2016
6 Reasons to Watch Kythera Biopharm Inc. (AGN, PFE) May 01 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK